80.77
BATS BZX Real-Time Price
As of 11:10am ET
 -0.25 / -0.31%
Today’s Change
65.25
Today|||52-Week Range
92.64
-11.19%
Year-to-Date
Merck & Co. (MRK) Q2 2020 Earnings Call Transcript
Aug 01 / MotleyFool.com - Paid Partner Content
FDA grants accelerated review to Merck's MK-6482 for rare kidney cancer
Jul 29 / Seeking Alpha - Paid Partner Content
Merck to Begin Pivotal COVID-19 Antiviral Studies in September
Jul 31 / MotleyFool.com - Paid Partner Content
Better Coronavirus Stock: Moderna vs. VBI Vaccines
Jul 29 / MotleyFool.com - Paid Partner Content
Merck's (MRK) CEO Ken Frazier on Q2 2020 Results - Earnings Call Transcript
Jul 31 / Seeking Alpha - Paid Partner Content
Merck Declares Fresh Dividend; Yield Is 3.1%
Jul 28 / MotleyFool.com - Paid Partner Content
Checkmate Pharmaceuticals Begins IPO Process
Jul 31 / Seeking Alpha - Paid Partner Content
Merck declares $0.61 dividend
Jul 28 / Seeking Alpha - Paid Partner Content
Craving Healthcare: A Beginner's Guide And My 7 Picks
Jul 31 / Seeking Alpha - Paid Partner Content
Pfizer/BioNTech COVID-19 Vaccine: A Reality Check
Jul 28 / Seeking Alpha - Paid Partner Content
Merck's Q2 Sales Got Clobbered by COVID-19, but Still Beat Estimates
Jul 31 / MotleyFool.com - Paid Partner Content
Biotech Bonanza - Second Half Outlook
Jul 28 / Seeking Alpha - Paid Partner Content
Merck & Co., Inc. 2020 Q2 - Results - Earnings Call Presentation
Jul 31 / Seeking Alpha - Paid Partner Content
4 Reasons AstraZeneca Gave Daiichi Sankyo Another $1 Billion Upfront
Jul 28 / MotleyFool.com - Paid Partner Content
Merck +3% on Q2 beat; EPS guidance raised above expectations
Jul 31 / Seeking Alpha - Paid Partner Content
Lumos rises on sale of its priority voucher rights for $60M
Jul 27 / Seeking Alpha - Paid Partner Content
Merck EPS beats by $0.32, beats on revenue
Jul 31 / Seeking Alpha - Paid Partner Content
Wide-Moat Stocks On Sale - The August 2020 Heat Map
Jul 27 / Seeking Alpha - Paid Partner Content
Notable earnings before Friday's open
Jul 30 / Seeking Alpha - Paid Partner Content
Compugen: Clinical Data Supports COM701 As A Potential Breakthrough Cancer Treatment
Jul 27 / Seeking Alpha - Paid Partner Content
Merck Q2 2020 Earnings Preview
Jul 30 / Seeking Alpha - Paid Partner Content
Vanguard Health Care ETF: Outlook Remains Favorable Despite Higher Valuation
Jul 27 / Seeking Alpha - Paid Partner Content
FDA accepts Merck applications for expanded uses of Keytruda
Jul 30 / Seeking Alpha - Paid Partner Content
Stocks To Watch: Big Focus On Big Tech
Jul 25 / Seeking Alpha - Paid Partner Content
Introducing The Pale Blue Portfolio
Jul 29 / Seeking Alpha - Paid Partner Content
COVID-19 Takes Its Toll, But Roche Still Attractive For Longer-Term Investors
Jul 24 / Seeking Alpha - Paid Partner Content